HOME >> MEDICINE >> NEWS
Animal models show that anabolic steroids flip the adolescent brain's switch for aggression

Anabolic steroids not only make teens more aggressive, but may keep them that way into young adulthood. The effect ultimately wears off but there may be other, lasting consequences for the developing brain. These findings, published in February's Behavioral Neuroscience, also showed that aggression rose and fell in synch with neurotransmitter levels in the brain's aggression control region. Behavioral Neuroscience is published by the American Psychological Association (APA).

Neuroscientists are deeply concerned about rising adolescent abuse of anabolic-androgenic steroids (AASs), given the National Institute on Drug Abuse's estimate that nearly half a million eighth- and 10th-grade students abuse AASs each year. Not only do steroids set kids up for heavier use of steroids and other drugs later in life, but long-term users can suffer from mood swings, hallucinations and paranoia; liver damage; high blood pressure; as well as increased risk of heart disease, stroke and some types of cancer. Withdrawal often brings depression, and recent research suggests that some AASs may even be habit-forming.

Overseen by Richard Melloni Jr., PhD, of Northeastern University in Boston, the current study of 76 adolescent hamsters compared how individual hamsters behaved when another hamster was put into their cages. Normally mild-mannered hamsters still defend their turf, learning aggression during puberty by play-fighting, much like humans. Their roughhousing normally includes wrestling and nibbling pretty tame stuff.

However, hamsters injected with commonly used steroids (suspended in oil) became extremely aggressive. Even after the drug was withdrawn, the newly vicious hamsters attacked, bit and chased the intruders. In fact, their aggressiveness measured ten times greater than that of control hamsters injected with oil only. Their full-blown aggression clearly drug-induced -- lasted for nearly two weeks of withdrawal, the equivalent of half
'"/>

Contact: Pam Willenz
public.affairs@apa.org
American Psychological Association
26-Feb-2006


Page: 1 2 3

Related medicine news :

1. Animal study leading to new treatments for hemorrhagic shock and uncontrolled abdominal hemorrhage
2. Animal study identifies promising new target for brain tumor therapy
3. Animal BiP levels determine amount of recovery sleep needed following prolonged wakefulness
4. Animal studies suggest vegetables may reduce hardening of arteries
5. Animal research suggests perimenopause is a critical time for womens health
6. Animal disease reports to be released at July 18 news conference at AVMA convention
7. Animal research suggests new treatment target for epilepsy
8. Animal model demonstrates course of epilepsy
9. Latest IPCC report highlights need for integrated climate/human behavior models
10. Dopamine imbalances cause sleep disorders in animal models of Parkinsons disease and schizophrenia
11. Proteins spur diabetic mice models to grow blood vessels, nerves

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/4/2020)... ... July 03, 2020 , ... The latest ... latest content hub— Future Lab: COVID-19 R&D . , Future Lab ... and products within specific scientific niches. Since their launch four years ago, the ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... the treatment of autoimmune diseases. Its lead indication is vitiligo. Vitiligo patients ... this time. , While vitiligo is equally prevalent in all ethnic ...
(Date:7/2/2020)... ... ... Allegheny Health Network (AHN) today announced that John S. Lee, MD, has ... Dr. Lee succeeds Robert White, MD, who announced his plans for retirement earlier this ... help support a seamless transition. , Dr. Lee joins AHN from Edward-Elmhurst Healthcare, based ...
(Date:7/1/2020)... ... 01, 2020 , ... ABSTRAX, an industry leader in the ... new terpene infused product line including custom rolling papers, cones, flat wraps, and ... and flavors worldwide. , “We’ve made it easier than ever for brands to ...
(Date:7/1/2020)... ... July 01, 2020 , ... G-CON ... been selected by Codiak BioSciences to support its cleanroom build out at its ... infrastructure for the drug substance and product manufacturing for its clinical pipeline. , ...
Breaking Medicine News(10 mins):
(Date:7/1/2020)... ... 01, 2020 , ... Lumeda Inc. (“Lumeda”), a ... formation of its Scientific Advisory Board with the appointment of a panel of ... to support company development and introduction of its PDT products to the clinic. ...
(Date:6/25/2020)... ... 25, 2020 , ... R3 Medical Training announced today it is now enrolling ... locations. The first course is August 6-7, 2020 in San Diego and the second ... a Virtual Live Stream option. , The two day agenda for each course is ...
(Date:6/25/2020)... ... 2020 , ... The FSHD Society announced the opening today ... conducted entirely online for the first time in the organization’s history. The conference ... of state-of-the-art research on facioscapulohumeral muscular dystrophy (FSHD). A record 210 researchers, clinicians, ...
Breaking Medicine Technology:
Cached News: